ketanserin has been researched along with Ophthalmoplegia, Progressive Supranuclear in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stamelou, M | 1 |
| Matusch, A | 1 |
| Elmenhorst, D | 1 |
| Hurlemann, R | 1 |
| Eggert, KM | 1 |
| Zilles, K | 1 |
| Oertel, WH | 1 |
| Höglinger, GU | 1 |
| Bauer, A | 1 |
| Maloteaux, JM | 1 |
| Laterre, EC | 1 |
| Laduron, PM | 1 |
| Javoy-Agid, F | 1 |
| Agid, Y | 1 |
2 other studies available for ketanserin and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
Nigrostriatal upregulation of 5-HT2A receptors correlates with motor dysfunction in progressive supranuclear palsy.
Topics: Aged; Brain Mapping; Corpus Striatum; Female; Fluorine Radioisotopes; Humans; Ketanserin; Magnetic R | 2009 |
Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy.
Topics: Aged; Aged, 80 and over; Dementia; Humans; Ketanserin; Middle Aged; Parkinson Disease; Receptors, Se | 1988 |